New painkiller could replace opioids after skin cancer surgery
NCT ID NCT07575230
First seen May 14, 2026 · Last updated May 15, 2026 · Updated 2 times
Summary
This study tests if a new non-opioid painkiller (suzetrigine) works as well as a standard opioid for pain after Mohs skin cancer surgery. About 75 adults having Mohs surgery will receive either suzetrigine or hydrocodone/acetaminophen. The goal is to see if the non-opioid option can control pain and reduce the need for opioids.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MOHS MICROGRAPHIC SURGERY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Baylor University Medical Center
Dallas, Texas, 75246, United States
Conditions
Explore the condition pages connected to this study.